Skip to main content

Pregabalin

NDC 62332-126 · Alembic Pharmaceuticals Inc.

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength300 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

62332-126-10 — 100 CAPSULE in 1 CARTON (62332-126-10)

62332-126-30 — 30 CAPSULE in 1 BOTTLE (62332-126-30)

62332-126-71 — 500 CAPSULE in 1 BOTTLE (62332-126-71)

62332-126-90 — 90 CAPSULE in 1 BOTTLE (62332-126-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62135-445 — Pregabalin, 62135-446 — Pregabalin, 62135-447 — Pregabalin, 62332-119 — Pregabalin, 62332-120 — Pregabalin, 62332-121 — Pregabalin, 62332-122 — Pregabalin, 62332-123 — Pregabalin, 62332-124 — Pregabalin, 62332-125 — Pregabalin, 63629-8195 — PREGABALIN, 63629-8196 — PREGABALIN, 63629-8197 — PREGABALIN, 63629-8198 — PREGABALIN, 63629-8199 — PREGABALIN, 63629-8208 — PREGABALIN, 63629-8239 — PREGABALIN, 63629-8248 — PREGABALIN, 64980-410 — PREGABALIN, 64980-411 — PREGABALIN, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels